CYP24A1 and hypercalcemia disease: The critical role of CYP24A1 in the catabolism of 1,25(OH)2D3 in humans was noted in studies of very young children and adults with inactivating mutations in CYP24A1 who presented with hypercalcemia and hypercalciuria [8].